Giant prostatic hyperplasia and its causes

Anglickis, Marius; Platkevičius, Gediminas; Stulpinas, Rokas; Miklyčiūtė, Lina; Anglickienė, Giedrė; Keina, Vytautas; Štarolis, Edmundas; Gradauskas, Audrius

doi:10.6001/actamedica.v26i4.4209

Cited by 4 publications

(3 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Kyei M et al [14] reported a similar PSA level. In one observation, An-glickis M [15] showed that volume influenced the total PSA. Indeed, reporting the history of a patient with giant prostatic hyperplasia, the PSA went from 77.5 ng/ml for a prostate volume of 371 ml to more than 100 ng/lm when the prostate volume reached 800 ml in a context of chronic urinary retention.…”

Section: Discussionmentioning

confidence: 99%

Evaluating the Influence of the Prostate Weight on the Morbidity and Mortality of Transvesical Open Prostatectomy: Prospective Analysis of 108 Cases in the Urology-Andrology Department of the Ignace Deen National Hospital in Conakry

Diallo,

Barry

et al. 2024

OJU

View full text Add to dashboard Cite

Introduction: Open transvesical prostatectomy remains today one of the most effective approaches for the management of benign prostatic hyperplasia despite the fact that, this method is associated with multiple complications. The objective of this study was to evaluate the influence of prostate weight on the morbidity and mortality of transvesical prostatectomy for adenoma in the urology-andrology department of the Ignace Deen National Hospital. Materials and Methods: This was a prospective, longitudinal and analytical study lasting 6 months, from March 1, 2022 to August 31, 2022 including patients admitted and operated on by open transvesical prostatectomy by assessing the influence of prostate weight on the morbidity and mortality of transvesical adenomectomies. Results: 108 patients were included in our study, the average age of our patients was 70 ± 7.7 years, cultivators were the most represented profession with 38.89%, and hypertension was the most represented comorbidity with 75%. 33.06% of cases became complicated and surgical wound infection was the main complication with a frequency of 17.40%. Statistical analysis did not conclude that, the prostate weight does not have a statistically significant influence on the morbidity and mortality of transvesical open prostatectomy for benign prostatic hyperplasia.

show abstract

Section: Discussionmentioning

confidence: 99%

Evaluating the Influence of the Prostate Weight on the Morbidity and Mortality of Transvesical Open Prostatectomy: Prospective Analysis of 108 Cases in the Urology-Andrology Department of the Ignace Deen National Hospital in Conakry

Diallo,

Barry

et al. 2024

OJU

View full text Add to dashboard Cite

show abstract

“…Benign Prostatic Hypertrophy (BPH) affects at least one-third of men over 60 years [ 1 ] and its incidence is age related [ 2 ]. The term giant prostatic hyperplasia (GPH) refers to prostates larger than 500 g [ 3 ]. We present a case of a 72-year-old man with a GPH who presented kidney injury due to bilateral hydronephrosis and no urinary retention.…”

Section: Introductionmentioning

confidence: 99%

Conservative approach for a giant prostatic hyperplasia of 1280 ml: a case report and literature review

Quaresima,

Tramanzoli,

Fasanella

et al. 2023

Journal of Surgical Case Reports

View full text Add to dashboard Cite

Benign Prostatic Hypertrophy (BPH) affects at least one-third of men over 60 years. A giant prostatic hyperplasia (GPH) is a prostate enlargement that exceeds 500 g. We present a case of a 72-year-old man with a GPH volume of 1280 ml, referred to our hospital for a worsening of the lower urinary tract symptoms (LUTS), bilateral loin pain and kidney failure. Although the patient had a negligible post-void residual urine, he had bilateral hydronephrosis. The patient was managed conservatory because of a high anesthesiologic risk but a bilateral percutaneous nephrostomy was placed soon due to kidney function worsening. The presence of serious comorbidities and the resolution of the loin pain and the renal failure, achieved first with the nephrostomy and then with periodic replacement of ureteral stents, along with an improvement of the LUTS obtained with medical therapy, have oriented us towards a conservative management of the patient.

show abstract

“…Giant prostatic hyperplasia (GPH) is defined as BPH over 500 cc. 1 To date, no more than 20 cases of GPH are reported in the literature, and the largest to be treated by holmium laser enucleation (HoLEP) was 400 cc. 2 We report a HoLEP of a 696 cc GPH.…”

Section: Introductionmentioning

confidence: 99%

Holmium laser enucleation of a 696 cc prostate (HoLEP): The largest reported in the literature

Borojeni¹,

Kosseifi²,

Dallongeville³

et al. 2022

Urology Case Reports

View full text Add to dashboard Cite

Giant prostatic hyperplasia and its causes

Cited by 4 publications

References 13 publications

Evaluating the Influence of the Prostate Weight on the Morbidity and Mortality of Transvesical Open Prostatectomy: Prospective Analysis of 108 Cases in the Urology-Andrology Department of the Ignace Deen National Hospital in Conakry

Evaluating the Influence of the Prostate Weight on the Morbidity and Mortality of Transvesical Open Prostatectomy: Prospective Analysis of 108 Cases in the Urology-Andrology Department of the Ignace Deen National Hospital in Conakry

Conservative approach for a giant prostatic hyperplasia of 1280 ml: a case report and literature review

Holmium laser enucleation of a 696 cc prostate (HoLEP): The largest reported in the literature

Contact Info

Product

Resources

About